GB

Ganesh Bhat

Director Director DIN 03329087
DIN 03329087 First appointment Dec 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ganesh Bhat

Data last updated:

Ganesh Bhat was a Director at Alkameyst Life Private Limited (2013–2016) and Director at Revathi Shares And Securities Pvt Ltd (from 2010). The companies operate in Pharma.

DIN 03329087
Primary Designation Director
Industry Pharma
First Appointment 15 Dec 2010
Oldest Company Age 34 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alkameyst Life Private Limited U74110MH2013PTC245708
Director16 Jul 20132013₹274 Cr (FY 2018)Active
Director15 Dec 20101992Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Revathi Shares And Securities Pvt Ltd
Alkameyst Life Private Limited
Premium access

Shareholding and investment profile for Ganesh Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesh Bhat

Ganesh Bhat was first appointed on 15 Dec 2010 as Director at Revathi Shares And Securities Pvt Ltd. The most recent appointment on record is 16 Jul 2013 at Alkameyst Life Private Limited.

Ganesh Bhat held 2 earlier board appointments: Alkameyst Life Private Limited (Director, 16 Jul 2013 to 19 Mar 2016); Revathi Shares And Securities Pvt Ltd (Director, from 15 Dec 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available